To include your compound in the COVID-19 Resource Center, submit it here.

Wave Life Sciences, Pfizer deal

The companies partnered to design and develop stereopure nucleic acid therapeutics for metabolic diseases. Wave will design and develop the nucleic acids from discovery through clinical candidate selection. The

Read the full 297 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE